191 related articles for article (PubMed ID: 37242777)
1. Antiparasitic Activity of
Peres RB; Batista MM; Bérenger ALR; Camillo FDC; Figueiredo MR; Soeiro MNC
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242777
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Phenotypic Activity and In Silico Analysis of Natural Products from Brazilian Biodiversity on
Peres RB; Fiuza LFA; da Silva PB; Batista MM; Camillo FDC; Marques AM; de C Brito L; Figueiredo MR; Soeiro MNC
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577145
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.
Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB
Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938
[TBL] [Abstract][Full Text] [Related]
5. Neolignans from leaves of Nectandra leucantha (Lauraceae) display in vitro antitrypanosomal activity via plasma membrane and mitochondrial damages.
Grecco SS; Costa-Silva TA; Jerz G; de Sousa FS; Londero VS; Galuppo MK; Lima ML; Neves BJ; Andrade CH; Tempone AG; Lago JHG
Chem Biol Interact; 2017 Nov; 277():55-61. PubMed ID: 28864277
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic Screening In Vitro of Novel Aromatic Amidines against Trypanosoma cruzi.
Simões-Silva MR; Nefertiti AS; De Araújo JS; Batista MM; Da Silva PB; Bahia MT; Menna-Barreto RS; Pavão BP; Green J; Farahat AA; Kumar A; Boykin DW; Soeiro MN
Antimicrob Agents Chemother; 2016 Aug; 60(8):4701-7. PubMed ID: 27216059
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.
Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN
Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830
[TBL] [Abstract][Full Text] [Related]
8. In vitro and In vivo Biological Activity of Two Aryloxy-naphthoquinones in Mice Infected with Trypanosoma cruzi Strains.
Vázquez K; Moreno-Rodríguez A; Domínguez-Díaz LR; Bertrand J; Salas CO; Rivera G; Pérez Cervera Y; Bocanegra-García V
Med Chem; 2024 May; ():. PubMed ID: 38757318
[TBL] [Abstract][Full Text] [Related]
9. Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy.
Simões-Silva MR; De Araújo JS; Oliveira GM; Demarque KC; Peres RB; D'Almeida-Melo I; Batista DGJ; Da Silva CF; Cardoso-Santos C; Da Silva PB; Batista MM; Bahia MT; Soeiro MNC
Biochem Pharmacol; 2017 Dec; 145():46-53. PubMed ID: 28870526
[TBL] [Abstract][Full Text] [Related]
10. Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
Araujo-Lima CF; Peres RB; Silva PB; Batista MM; Aiub CAF; Felzenszwalb I; Soeiro MNC
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987140
[TBL] [Abstract][Full Text] [Related]
11. Enyne acetogenins from Porcelia macrocarpa displayed anti-Trypanosoma cruzi activity and cause a reduction in the intracellular calcium level.
Thevenard F; Brito IA; Costa-Silva TA; Tempone AG; Lago JHG
Sci Rep; 2023 Jun; 13(1):10254. PubMed ID: 37355735
[TBL] [Abstract][Full Text] [Related]
12. Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones.
de Castro SL; Batista DG; Batista MM; Batista W; Daliry A; de Souza EM; Menna-Barreto RF; Oliveira GM; Salomão K; Silva CF; Silva PB; Soeiro Mde N
Mol Biol Int; 2011; 2011():306928. PubMed ID: 22091400
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI
Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435
[TBL] [Abstract][Full Text] [Related]
14. In silico and in vitro assessment of anti-Trypanosoma cruzi efficacy, genotoxicity and pharmacokinetics of pentasubstituted pyrrolic Atorvastatin-aminoquinoline hybrid compounds.
Araujo-Lima CF; Carvalho RCC; Peres RB; Fiuza LFA; Galvão BVD; Castelo-Branco FS; Bastos MM; Boechat N; Felzenszwalb I; Soeiro MNC
Acta Trop; 2023 Jun; 242():106924. PubMed ID: 37037291
[TBL] [Abstract][Full Text] [Related]
15. Identification of Pyrazolo[3,4-e][1,4]thiazepin based CYP51 inhibitors as potential Chagas disease therapeutic alternative: In vitro and in vivo evaluation, binding mode prediction and SAR exploration.
Ferreira de Almeida Fiuza L; Peres RB; Simões-Silva MR; da Silva PB; Batista DDGJ; da Silva CF; Nefertiti Silva da Gama A; Krishna Reddy TR; Soeiro MNC
Eur J Med Chem; 2018 Apr; 149():257-268. PubMed ID: 29501946
[TBL] [Abstract][Full Text] [Related]
16.
Nefertiti ASG; Batista MM; Da Silva PB; Batista DGJ; Da Silva CF; Peres RB; Torres-Santos EC; Cunha-Junior EF; Holt E; Boykin DW; Brun R; Wenzler T; Soeiro MNC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203485
[TBL] [Abstract][Full Text] [Related]
17. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
18. Reevaluating the Trypanosoma cruzi proteomic map: The shotgun description of bloodstream trypomastigotes.
Brunoro GV; Caminha MA; Ferreira AT; Leprevost Fda V; Carvalho PC; Perales J; Valente RH; Menna-Barreto RF
J Proteomics; 2015 Feb; 115():58-65. PubMed ID: 25534883
[TBL] [Abstract][Full Text] [Related]
19. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS
Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142
[TBL] [Abstract][Full Text] [Related]
20. A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi.
Rodrigues JH; Ueda-Nakamura T; Corrêa AG; Sangi DP; Nakamura CV
PLoS One; 2014; 9(1):e85706. PubMed ID: 24465654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
